rs2621416
|
|
G |
0.800 |
GeneticVariation |
GWASDB |
Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.
|
23349640 |
2013 |
rs2621416
|
|
G |
0.800 |
GeneticVariation |
GWASCAT |
Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.
|
23349640 |
2013 |
rs2647045
|
|
|
0.800 |
GeneticVariation |
GWASDB |
Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.
|
23349640 |
2013 |
rs2647045
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.
|
23349640 |
2013 |
rs4530903
|
|
T |
0.800 |
GeneticVariation |
GWASDB |
Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.
|
23349640 |
2013 |
rs4530903
|
|
T |
0.800 |
GeneticVariation |
GWASCAT |
Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.
|
23349640 |
2013 |
rs11466782
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The ADAM19 rs11466782 SNP was associated with an increased risk of lymphoma (OR, 1.73; 95% CI, 1.28-2.35; Padditive=0.0004), and the ICAM3 rs2304240 (OR, 0.67; 95% CI, 0.52-0.86; Padditive=0.002) and the PTGDR rs708486 SNPs (OR, 0.75; 95% CI, 0.63-0.90; Padditive=0.002) were associated with reduced risk of lymphoma.
|
21239057 |
2011 |
rs1057519781
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Activation of IGF-1R pathway and NPM-ALK G1269A mutation confer resistance to crizotinib treatment in NPM-ALK positive lymphoma.
|
31177400 |
2019 |
rs2231231
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Accordingly, we analyzed the association between a single-nucleotide polymorphism locus of aquaporin 3 (rs2231231) and Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (EBVaNPC), lymphoma (EBVaL), and gastric carcinoma in China.
|
30110699 |
2018 |
rs113488022
|
|
|
0.030 |
GeneticVariation |
BEFREE |
These cases illustrate the expanding spectrum of BRAF V600E-positive histiocytic and dendritic cell tumors and suggest that attention should be paid to lymphomas for possible coincident presentation of these disorders.
|
25787243 |
2015 |
rs113488022
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The presence of the BRAF c.1799T>A V600E mutation was recently described in cases of hairy cell leukemia (HCL) but not in other common lymphomas.
|
23161722 |
2012 |
rs113488022
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The BRAF-V600E mutation defines genetically hairy cell leukemia among B-cell leukemias and lymphomas.
|
23349307 |
2013 |
rs121913377
|
|
|
0.030 |
GeneticVariation |
BEFREE |
These cases illustrate the expanding spectrum of BRAF V600E-positive histiocytic and dendritic cell tumors and suggest that attention should be paid to lymphomas for possible coincident presentation of these disorders.
|
25787243 |
2015 |
rs121913377
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The presence of the BRAF c.1799T>A V600E mutation was recently described in cases of hairy cell leukemia (HCL) but not in other common lymphomas.
|
23161722 |
2012 |
rs121913377
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The BRAF-V600E mutation defines genetically hairy cell leukemia among B-cell leukemias and lymphomas.
|
23349307 |
2013 |
rs1883832
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We hypothesized that single nucleotide polymorphisms (SNPs) in TNFRSF5 and TNFSF5 encoding the CD40 and CD154 proteins, respectively, influence lymphoma risk, particularly a functional TNFRSF5 SNP (-1C>T, rs1883832) associated with reduced B-cell CD40 expression.
|
18287517 |
2008 |
rs2466571
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In line with a previous study, rs2466571 in CD46 (HR = 0.73, 95% CI 0.58-0.91, p = 0.006) showed nominal association with lymphoma progression, as did two highly linked SNPs in IL8 (rs4073 HR = 0.78, 95% CI 0.62-0.97, p = 0.02; rs2227307 HR = 0.75, 95% CI 0.60-0.94, p = 0.01) previously associated with overall survival.
|
25294155 |
2014 |
rs751837
|
|
|
0.010 |
GeneticVariation |
BEFREE |
By following two-stage GWAS approach and an independent replication study, we identified disease susceptibility locus within intron 3 of the CDC42BPB gene on 14q32 (rs751837; P=3.30 × 10(-7) and odds ratio (OR) of 3.5), a region of frequent chromosomal translocations in lymphoma, and variant on 13q12 (rs7097; P=6.57 × 10(-6) and OR of 1.43) which harbors the notch signaling mediator, LNX2 gene.
|
21471979 |
2011 |
rs11547328
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We propose that similarly to typical human MCL and its blastoid or cyclin-D1 variants that correspond to the same genetic entity, MCL-like lymphomas of c-myc-3'RR/ p53+/- mice and c-myc-3'RR/Cdk4(R24C) mice represent a spectrum of the same entity.
|
22592113 |
2012 |
rs10190751
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A comparison of 183 patients with follicular lymphoma and 233 population controls revealed an increased lymphoma risk associated with the rs10190751 A genotype causing c-FLIP(R) expression.
|
19439735 |
2009 |
rs74790047
|
|
|
0.010 |
GeneticVariation |
BEFREE |
For individual cancer types, p.D140E was associated with lung cancer (adjusted OR, 3.99; 95% CI, 2.07-7.67; P < 0.001), malignant lymphoma (adjusted OR, 3.24; 95% CI, 1.43-7.33; P = 0.005), and rectum cancer (adjusted OR, 6.23; 95% CI, 2.31-16.8; P < 0.001).
|
25407497 |
2015 |
rs555607708
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs2227307
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In line with a previous study, rs2466571 in CD46 (HR = 0.73, 95% CI 0.58-0.91, p = 0.006) showed nominal association with lymphoma progression, as did two highly linked SNPs in IL8 (rs4073 HR = 0.78, 95% CI 0.62-0.97, p = 0.02; rs2227307 HR = 0.75, 95% CI 0.60-0.94, p = 0.01) previously associated with overall survival.
|
25294155 |
2014 |
rs4073
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In line with a previous study, rs2466571 in CD46 (HR = 0.73, 95% CI 0.58-0.91, p = 0.006) showed nominal association with lymphoma progression, as did two highly linked SNPs in IL8 (rs4073 HR = 0.78, 95% CI 0.62-0.97, p = 0.02; rs2227307 HR = 0.75, 95% CI 0.60-0.94, p = 0.01) previously associated with overall survival.
|
25294155 |
2014 |
rs1802710
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Analysis of 47 brain tumors and 55 lymphomas found that 23 and 29 of them were heterozygous for rs1802710, respectively.
|
15010842 |
2004 |